Correlation Between Bristol Myers and Mesoblast
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Mesoblast, you can compare the effects of market volatilities on Bristol Myers and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Mesoblast.
Diversification Opportunities for Bristol Myers and Mesoblast
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Bristol and Mesoblast is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of Bristol Myers i.e., Bristol Myers and Mesoblast go up and down completely randomly.
Pair Corralation between Bristol Myers and Mesoblast
Considering the 90-day investment horizon Bristol Myers is expected to generate 3.25 times less return on investment than Mesoblast. But when comparing it to its historical volatility, Bristol Myers Squibb is 2.58 times less risky than Mesoblast. It trades about 0.14 of its potential returns per unit of risk. Mesoblast is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 695.00 in Mesoblast on September 2, 2024 and sell it today you would earn a total of 463.00 from holding Mesoblast or generate 66.62% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Bristol Myers Squibb vs. Mesoblast
Performance |
Timeline |
Bristol Myers Squibb |
Mesoblast |
Bristol Myers and Mesoblast Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bristol Myers and Mesoblast
The main advantage of trading using opposite Bristol Myers and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
Mesoblast vs. Aditxt Inc | Mesoblast vs. Lipocine | Mesoblast vs. Connect Biopharma Holdings | Mesoblast vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |